20 / 24
Comparison of treatment sequences
•
No face to face trials comparing different treatment sequences
•
Clinical approach to select chemotherapy:
•
Efficacy
•
Toxicity
•
Based on RCT
•
Biomarker driven therapy not ready for the prime time